Figures & data
Figure 1 Schematic of positively charged (AmS-IONPs) and negatively charged (COOH-AmS-IONPs) nanoparticles and their physical properties.
Notes: Measurements were performed in triplicate samples using a Nano-partica SZ-100 series instrument from Horiba. Values represent the mean ± standard error of the mean (n = 3).
Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.
![Figure 1 Schematic of positively charged (AmS-IONPs) and negatively charged (COOH-AmS-IONPs) nanoparticles and their physical properties.Notes: Measurements were performed in triplicate samples using a Nano-partica SZ-100 series instrument from Horiba. Values represent the mean ± standard error of the mean (n = 3).Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.](/cms/asset/25d35b8d-1aeb-4824-a164-9b03fd72d538/dijn_a_39048_f0001_b.jpg)
Figure 2 bEnd.3 cell (A), astrocyte (B), and neuron (C) viability following a 24-hour exposure to various concentrations of AmS-IONPs.
Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. *Indicates P < 0.05 compared to control; **indicates P < 0.01.
Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.
![Figure 2 bEnd.3 cell (A), astrocyte (B), and neuron (C) viability following a 24-hour exposure to various concentrations of AmS-IONPs.Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. *Indicates P < 0.05 compared to control; **indicates P < 0.01.Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.](/cms/asset/d9489977-611d-4bf3-a380-ad45337be658/dijn_a_39048_f0002_b.jpg)
Figure 3 MTT assay of COOH-AmS-IONPs to bEnd.3 cells (A), astrocytes (B), and neurons (C).
Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. ***Indicates P < 0.001 compared to control; +indicates P < 0.05 compared to the same concentration without a magnet.
Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AmS-IONPs, aminosilane-coated iron oxide nanoparticles.
![Figure 3 MTT assay of COOH-AmS-IONPs to bEnd.3 cells (A), astrocytes (B), and neurons (C).Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. ***Indicates P < 0.001 compared to control; +indicates P < 0.05 compared to the same concentration without a magnet.Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AmS-IONPs, aminosilane-coated iron oxide nanoparticles.](/cms/asset/5210b084-f995-40d8-92fc-6d8380c3fdb6/dijn_a_39048_f0003_b.jpg)
Figure 4 Cellular uptake of AmS-IONPs in bEnd.3 cells. Amount of iron accumulation in the cells normalized to protein in time- and concentration-dependent manner (A). The cells were incubated with AmS-IONPs for 1.5 hours at 37°C (B) or 4°C (C).
Note: Values represent the mean ± standard error of the mean of three samples per treatment group.
Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.
![Figure 4 Cellular uptake of AmS-IONPs in bEnd.3 cells. Amount of iron accumulation in the cells normalized to protein in time- and concentration-dependent manner (A). The cells were incubated with AmS-IONPs for 1.5 hours at 37°C (B) or 4°C (C).Note: Values represent the mean ± standard error of the mean of three samples per treatment group.Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.](/cms/asset/1a87c024-6ecd-4882-877c-ad045bf86646/dijn_a_39048_f0004_b.jpg)